[(Bromomethyl)phenyl]methyl-Conjugated Chalcone Derivatives as Potential Lung Cancer Inhibitors: Structure Modification, Molecular Docking, Molecular Dynamics and In Vitro Validation
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27146104 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Nathaporn Cheechana und 6 weiteren Autor:innen. Beteiligte Einrichtung: Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand. Hauptthemen laut MEDLINE: Lung Neoplasms, Chalcones, Antineoplastic Agents, Chalcone. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chalcones from medicinal plants are attractive starting points for anticancer lead discovery, and this study aimed to improve the anti-NSCLC potential of 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone (DMC) from Syzygium nervosum through targeted structural modification and mechanistic computational analysis. Air-dried seeds were extracted with CH2Cl2, DMC was purified by silica gel chromatography and crystallization, and its structure was confirmed by HRMS, FTIR and NMR; 4′-O-derivatization with meta– or para–[(bromomethyl)phenyl]methyl groups afforded derivatives 2a and 2b (89–92% yield). Antiproliferative activity and cytotoxicity were evaluated by MTT assay in NSCLC cell lines (A549, NCI-H460) and normal lung fibroblasts (MRC-5) with osimertinib as a reference. Derivatives 2a and 2b showed enhanced activity against NCI-H460 (IC50 = 7.97 ± 0.62 µM and 7.91 ± 2.77 µM) while remaining weak against A549, and they were less cytotoxic to MRC-5 (IC50 ≥ 50 µM and 16.08 ± 0.45 µM) than osimertinib (IC50 = 3.43 ± 0.35 µM). DFT/MEP analyses, docking to wild-type EGFR (1M17; redocking RMSD 1.228 Å), and 500 ns × 3 replica MD simulations supported improved EGFR binding stability for 2a/2b, with MM/GBSA indicating favorable binding free energies (−28.78 ± 6.11 and −21.99 ± 9.39 kcal/mol). Overall, 4′-O-functionalization of DMC generated lead derivatives with improved in vitro activity in NCI-H460 and computationally supported target–ligand stabilization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand.
- Department of Chemistry, Faculty of Science, Chiang Mai University, 239 Huay Kaew Road, Chiang Mai 50200, Thailand.
- Department of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.
- Department of Chemistry, Faculty of Science, Khon Kaen University, Khon Kaen 40002, Thailand.
- Center of Excellence in Materials Science and Technology, Chiang Mai University, 239 Huay Kaew Road, Chiang Mai 50200, Thailand.
- Division of Biochemistry and Biochemical Innovation, Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
ORCID-Profile: Kraikrit Utama, Padchanee Sangthong
Zitieren
APA
Cheechana, N., Khamto, N., Utama, K., Kongsak, C., Rithchumpon, P., Sangthong, P., & Meepowpan, P. (2026). [(Bromomethyl)phenyl]methyl-Conjugated Chalcone Derivatives as Potential Lung Cancer Inhibitors: Structure Modification, Molecular Docking, Molecular Dynamics and In Vitro Validation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27146104
Vancouver
Cheechana N, Khamto N, Utama K, Kongsak C, Rithchumpon P, Sangthong P, et al. [(Bromomethyl)phenyl]methyl-Conjugated Chalcone Derivatives as Potential Lung Cancer Inhibitors: Structure Modification, Molecular Docking, Molecular Dynamics and In Vitro Validation. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27146104
BibTeX
@article{Cheechana2026,
author = {Cheechana, Nathaporn and Khamto, Nopawit and Utama, Kraikrit and Kongsak, Chawanakorn and Rithchumpon, Puracheth and Sangthong, Padchanee and Meepowpan, Puttinan},
title = {[(Bromomethyl)phenyl]methyl-Conjugated Chalcone Derivatives as Potential Lung Cancer Inhibitors: Structure Modification, Molecular Docking, Molecular Dynamics and In Vitro Validation},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27146104}
}
EUVIMED